CD274 and neoplasm: The inhibition of PIM1 on MDSCs led to the reduced number of MDSCs in the TME, restoring the anti-tumor function of cytotoxic T cells, improving the efficacy of PD-L1 blockade, and overcoming the resistance in ICB-resistant patients (91).